Jointown Pharmaceutical Group Future Growth

Future criteria checks 1/6

Jointown Pharmaceutical Group is forecast to grow earnings and revenue by 17.1% and 8% per annum respectively. EPS is expected to grow by 15% per annum. Return on equity is forecast to be 10.4% in 3 years.

Key information

17.1%

Earnings growth rate

15.0%

EPS growth rate

Healthcare earnings growth	23.0%
Revenue growth rate	8.0%
Future return on equity	10.4%
Analyst coverage	Low
Last updated	08 Nov 2024

Recent future growth updates

Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Aug 29

Recent updates

We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Nov 17

Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Aug 29

Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

Aug 26

These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Aug 01

Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Jun 07

Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

May 21

Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Apr 05

Earnings and Revenue Growth Forecasts

SHSE:600998 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	179,870	3,082	N/A	4,296	4
12/31/2025	167,170	2,721	N/A	2,254	5
12/31/2024	156,373	2,353	N/A	4,515	4
9/30/2024	149,205	2,047	317	1,291	N/A
6/30/2024	147,953	2,039	82	1,029	N/A
3/31/2024	148,519	2,151	3,155	4,116	N/A
12/31/2023	150,140	2,174	3,699	4,748	N/A
9/30/2023	151,842	2,170	5,217	6,257	N/A
6/30/2023	151,797	2,159	5,409	6,559	N/A
3/31/2023	147,366	2,194	2,395	3,611	N/A
12/31/2022	140,424	2,085	2,743	3,986	N/A
9/30/2022	133,260	1,782	3,638	4,886	N/A
6/30/2022	128,411	1,545	1,345	2,656	N/A
3/31/2022	124,929	2,141	1,862	3,234	N/A
12/31/2021	122,407	2,448	2,073	3,459	N/A
9/30/2021	122,634	3,339	282	1,907	N/A
6/30/2021	121,491	3,988	3,113	4,802	N/A
3/31/2021	116,315	3,258	2,009	3,574	N/A
12/31/2020	110,860	3,075	1,987	3,444	N/A
9/30/2020	106,438	2,849	2,930	4,117	N/A
6/30/2020	102,417	2,242	2,025	3,152	N/A
3/31/2020	102,007	1,976	2,349	3,480	N/A
12/31/2019	99,497	1,727	1,576	2,768	N/A
9/30/2019	96,769	1,588	1,479	2,737	N/A
6/30/2019	93,116	1,547	1,882	3,123	N/A
3/31/2019	89,589	1,446	583	1,833	N/A
12/31/2018	87,136	1,341	-593	1,222	N/A
9/30/2018	83,230	1,262	-1,949	-231	N/A
6/30/2018	80,163	1,189	N/A	-2,213	N/A
3/31/2018	77,339	1,481	N/A	-2,221	N/A
12/31/2017	73,943	1,446	N/A	-1,012	N/A
9/30/2017	70,783	1,374	N/A	-2,586	N/A
6/30/2017	67,999	1,360	N/A	-198	N/A
3/31/2017	64,925	921	N/A	1,382	N/A
12/31/2016	61,557	877	N/A	431	N/A
9/30/2016	58,367	777	N/A	1,748	N/A
6/30/2016	55,482	754	N/A	193	N/A
3/31/2016	53,091	718	N/A	-783	N/A
12/31/2015	49,589	695	N/A	436	N/A
9/30/2015	46,895	640	N/A	-1,088	N/A
6/30/2015	45,049	602	N/A	-1,287	N/A
3/31/2015	43,171	566	N/A	-312	N/A
12/31/2014	41,068	561	N/A	-172	N/A
9/30/2014	39,273	533	N/A	-450	N/A
6/30/2014	37,189	509	N/A	-702	N/A
3/31/2014	35,150	493	N/A	-1,230	N/A
12/31/2013	33,438	478	N/A	138	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600998's forecast earnings growth (17.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 600998's earnings (17.1% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 600998's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600998's revenue (8% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 600998's revenue (8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600998's Return on Equity is forecast to be low in 3 years time (10.4%).

Jointown Pharmaceutical Group Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Price target decreased by 14% to CN¥6.41

Consensus EPS estimates fall by 13%

Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Consensus EPS estimates fall by 11%

Price target increased by 23% to CN¥9.48

Price target decreased by 10% to CN¥7.70

Recent updates

We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt

Price target decreased by 14% to CN¥6.41

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Jointown Pharmaceutical Group Co., Ltd to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 17%

Consensus EPS estimates fall by 13%

Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price

These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well

Jointown Pharmaceutical Group Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024

Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) announces an Equity Buyback for CNY 300 million worth of its shares.

Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward

Investor sentiment deteriorates as stock falls 23%

Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors

Consensus EPS estimates fall by 11%

Jointown Pharmaceutical Group Co., Ltd, Annual General Meeting, May 24, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 23% to CN¥9.48

Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)

Jointown Pharmaceutical Group Co., Ltd to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 18%

Jointown Pharmaceutical Group Co., Ltd to Report Fiscal Year 2023 Results on Apr 27, 2024

Price target decreased by 10% to CN¥7.70

Third quarter 2023 earnings released: EPS: CN¥1.16 (vs CN¥0.12 in 3Q 2022)

Investor sentiment deteriorates as stock falls 30%

Price target increased by 15% to CN¥12.04

Second quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.29 in 2Q 2022)

Jointown Pharmaceutical Group Co., Ltd to Report First Half, 2023 Results on Aug 29, 2023

Price target increased by 7.4% to CN¥15.62

First quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.23 in 1Q 2022)

Price target increased by 8.5% to CN¥14.54

Less than half of directors are independent

Consensus forecasts updated

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.12 in 3Q 2021)

Consensus forecasts updated

Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.77 in 2Q 2021)

Consensus EPS estimates fall by 48%

Price target decreased to CN¥13.40

Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) announces an Equity Buyback for CNY 600 million worth of its shares.

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.48 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.77 (vs CN¥0.37 in 2Q 2020)

Price target decreased to CN¥19.00

First quarter 2021 earnings released: EPS CN¥0.40 (vs CN¥0.32 in 1Q 2020)

New 90-day low: CN¥17.10

Price target raised to CN¥20.35

New 90-day high: CN¥18.60

Analysts update estimates

Third quarter earnings released

Annual earnings released: Earnings beat expectations

Jointown Pharmaceutical Group Co., Ltd. to Report Q3, 2020 Results on Oct 27, 2020

Jointown Pharmaceutical Group Co., Ltd. (SHSE:600998) intends to acquire remaining 51% stake in Hubei Buchang Jiuzhoutong Pharmaceutical Co., Ltd. from Shandong Buchang Pharmaceuticals Co., Ltd. (SHSE:603858) for CNY 21.8 million.

New 90-day low - CN¥17.39

Earnings released

New 90-day high - CN¥20.19

Jointown Pharmaceutical Group Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies